Vaccine Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Vaccine Type (Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines); Workflow Type (Downstream, Upstream); Application (Human Use, Veterinary), and Geography
Report Code: TIPRE00006980 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
A vaccine is a biological production that offers the acquired immunity of a specific disease. Numerous vaccines are available in the market to treat conditions as per patients' needs. Due to stringent regulations and standards of the government, vaccine manufacturers are mandatory to follow the guidelines for vaccine development. Nowadays, the pharmaceutical and biopharmaceutical industries have been coming with advanced technologies in vaccine manufacturing.
MARKET DYNAMICS
Vaccine contract manufacturing market is anticipated to grow in the forecast period owing to driving factors such as capacity development by contract manufacturers for vaccine manufacturing, rise in vaccination coverage, and vaccination improvement and strong vaccine pipeline. Moreover, rising healthcare expenditure in emerging markets and cost & time saving profits offered by contract services are also offering opportunity in the market growth during the forecast period.
MARKET SCOPE
The "Global Vaccine Contract Manufacturing Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of vaccine contract manufacturing market with detailed market segmentation by vaccine type, workflow type, application, and geography. The global vaccine contract manufacturing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading vaccine contract manufacturing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global vaccine contract manufacturing market is segmented on the basis of vaccine type, workflow type, and application. Based on vaccine type, the vaccine contract manufacturing market is segmented as inactivated vaccines, attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines. Based on workflow type, the vaccine contract manufacturing market is segmented as downstream and upstream. Based on application, the market is segmented as human use and veterinary.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global vaccine contract manufacturing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The vaccine contract manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting vaccine contract manufacturing market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vaccine contract manufacturing market in these regions.
The report covers key developments in the vaccine contract manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from vaccine contract manufacturing market are anticipated to lucrative growth opportunities in the future with the rising demand for vaccine contract manufacturing in the global market. Below mentioned is the list of few companies engaged in the vaccine contract manufacturing market.
The report also includes the profiles of key vaccine contract manufacturing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
A vaccine is a biological production that offers the acquired immunity of a specific disease. Numerous vaccines are available in the market to treat conditions as per patients' needs. Due to stringent regulations and standards of the government, vaccine manufacturers are mandatory to follow the guidelines for vaccine development. Nowadays, the pharmaceutical and biopharmaceutical industries have been coming with advanced technologies in vaccine manufacturing.
MARKET DYNAMICS
Vaccine contract manufacturing market is anticipated to grow in the forecast period owing to driving factors such as capacity development by contract manufacturers for vaccine manufacturing, rise in vaccination coverage, and vaccination improvement and strong vaccine pipeline. Moreover, rising healthcare expenditure in emerging markets and cost & time saving profits offered by contract services are also offering opportunity in the market growth during the forecast period.
MARKET SCOPE
The "Global Vaccine Contract Manufacturing Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of vaccine contract manufacturing market with detailed market segmentation by vaccine type, workflow type, application, and geography. The global vaccine contract manufacturing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading vaccine contract manufacturing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global vaccine contract manufacturing market is segmented on the basis of vaccine type, workflow type, and application. Based on vaccine type, the vaccine contract manufacturing market is segmented as inactivated vaccines, attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines. Based on workflow type, the vaccine contract manufacturing market is segmented as downstream and upstream. Based on application, the market is segmented as human use and veterinary.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global vaccine contract manufacturing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The vaccine contract manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting vaccine contract manufacturing market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vaccine contract manufacturing market in these regions.
The report covers key developments in the vaccine contract manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from vaccine contract manufacturing market are anticipated to lucrative growth opportunities in the future with the rising demand for vaccine contract manufacturing in the global market. Below mentioned is the list of few companies engaged in the vaccine contract manufacturing market.
The report also includes the profiles of key vaccine contract manufacturing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Lonza
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Merck KGaA
- AbbVie Inc.
- Cytovance Biologics
- Catalent, Inc.
- IDT Biologika
- ICON plc.
- Albany Molecular Research Inc. (AMRI)
- Charles River
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vaccine Contract Manufacturing Market - By Vaccine Type
1.3.2 Vaccine Contract Manufacturing Market - By Workflow Type
1.3.3 Vaccine Contract Manufacturing Market - By Application
1.3.4 Vaccine Contract Manufacturing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VACCINE CONTRACT MANUFACTURING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
5. VACCINE CONTRACT MANUFACTURING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VACCINE CONTRACT MANUFACTURING MARKET - GLOBAL MARKET ANALYSIS
6.1. VACCINE CONTRACT MANUFACTURING - GLOBAL MARKET OVERVIEW
6.2. VACCINE CONTRACT MANUFACTURING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VACCINE CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. INACTIVATED VACCINES
7.3.1. Overview
7.3.2. Inactivated Vaccines Market Forecast and Analysis
7.4. ATTENUATED VACCINES
7.4.1. Overview
7.4.2. Attenuated Vaccines Market Forecast and Analysis
7.5. SUBUNIT VACCINES
7.5.1. Overview
7.5.2. Subunit Vaccines Market Forecast and Analysis
7.6. TOXOID VACCINES
7.6.1. Overview
7.6.2. Toxoid Vaccines Market Forecast and Analysis
7.7. DNA VACCINES
7.7.1. Overview
7.7.2. DNA Vaccines Market Forecast and Analysis
8. VACCINE CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - WORKFLOW TYPE
8.1. OVERVIEW
8.2. WORKFLOW TYPE MARKET FORECASTS AND ANALYSIS
8.3. DOWNSTREAM
8.3.1. Overview
8.3.2. Downstream Market Forecast and Analysis
8.3.3. Fill & Finish Operations Market
8.3.3.1. Overview
8.3.3.2. Fill and Finish Operations Market Forecast and Analysis
8.3.4. Analytical & QC studies Market
8.3.4.1. Overview
8.3.4.2. Analytical and QC studies Market Forecast and Analysis
8.3.5. Packaging Market
8.3.5.1. Overview
8.3.5.2. Packaging Market Forecast and Analysis
8.4. UPSTREAM
8.4.1. Overview
8.4.2. Upstream Market Forecast and Analysis
8.4.3. Mammalian Expression Systems Market
8.4.3.1. Overview
8.4.3.2. Mammalian Expression Systems Market Forecast and Analysis
8.4.4. Bacterial Expression Systems Market
8.4.4.1. Overview
8.4.4.2. Bacterial Expression Systems Market Forecast and Analysis
8.4.5. Yeast Expression Systems Market
8.4.5.1. Overview
8.4.5.2. Yeast Expression Systems Market Forecast and Analysis
8.4.6. Baculovirus/Insect Expression Systems Market
8.4.6.1. Overview
8.4.6.2. Baculovirus/Insect Expression Systems Market Forecast and Analysis
8.4.7. Others Market
8.4.7.1. Overview
8.4.7.2. Others Market Forecast and Analysis
9. VACCINE CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HUMAN USE
9.3.1. Overview
9.3.2. Human Use Market Forecast and Analysis
9.4. VETERINARY
9.4.1. Overview
9.4.2. Veterinary Market Forecast and Analysis
10. VACCINE CONTRACT MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Vaccine Contract Manufacturing Market Overview
10.1.2 North America Vaccine Contract Manufacturing Market Forecasts and Analysis
10.1.3 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.1.4 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.1.5 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.1.6 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Vaccine Contract Manufacturing Market
10.1.6.1.1 United States Vaccine Contract Manufacturing Market by Vaccine Type
10.1.6.1.2 United States Vaccine Contract Manufacturing Market by Workflow Type
10.1.6.1.3 United States Vaccine Contract Manufacturing Market by Application
10.1.6.2 Canada Vaccine Contract Manufacturing Market
10.1.6.2.1 Canada Vaccine Contract Manufacturing Market by Vaccine Type
10.1.6.2.2 Canada Vaccine Contract Manufacturing Market by Workflow Type
10.1.6.2.3 Canada Vaccine Contract Manufacturing Market by Application
10.1.6.3 Mexico Vaccine Contract Manufacturing Market
10.1.6.3.1 Mexico Vaccine Contract Manufacturing Market by Vaccine Type
10.1.6.3.2 Mexico Vaccine Contract Manufacturing Market by Workflow Type
10.1.6.3.3 Mexico Vaccine Contract Manufacturing Market by Application
10.2. EUROPE
10.2.1 Europe Vaccine Contract Manufacturing Market Overview
10.2.2 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis
10.2.3 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.2.4 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.2.5 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.2.6 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Vaccine Contract Manufacturing Market
10.2.6.1.1 Germany Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.1.2 Germany Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.1.3 Germany Vaccine Contract Manufacturing Market by Application
10.2.6.2 France Vaccine Contract Manufacturing Market
10.2.6.2.1 France Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.2.2 France Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.2.3 France Vaccine Contract Manufacturing Market by Application
10.2.6.3 Italy Vaccine Contract Manufacturing Market
10.2.6.3.1 Italy Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.3.2 Italy Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.3.3 Italy Vaccine Contract Manufacturing Market by Application
10.2.6.4 Spain Vaccine Contract Manufacturing Market
10.2.6.4.1 Spain Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.4.2 Spain Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.4.3 Spain Vaccine Contract Manufacturing Market by Application
10.2.6.5 United Kingdom Vaccine Contract Manufacturing Market
10.2.6.5.1 United Kingdom Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.5.2 United Kingdom Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.5.3 United Kingdom Vaccine Contract Manufacturing Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Vaccine Contract Manufacturing Market Overview
10.3.2 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis
10.3.3 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.3.4 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.3.5 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Vaccine Contract Manufacturing Market
10.3.6.1.1 Australia Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.1.2 Australia Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.1.3 Australia Vaccine Contract Manufacturing Market by Application
10.3.6.2 China Vaccine Contract Manufacturing Market
10.3.6.2.1 China Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.2.2 China Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.2.3 China Vaccine Contract Manufacturing Market by Application
10.3.6.3 India Vaccine Contract Manufacturing Market
10.3.6.3.1 India Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.3.2 India Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.3.3 India Vaccine Contract Manufacturing Market by Application
10.3.6.4 Japan Vaccine Contract Manufacturing Market
10.3.6.4.1 Japan Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.4.2 Japan Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.4.3 Japan Vaccine Contract Manufacturing Market by Application
10.3.6.5 South Korea Vaccine Contract Manufacturing Market
10.3.6.5.1 South Korea Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.5.2 South Korea Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.5.3 South Korea Vaccine Contract Manufacturing Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Vaccine Contract Manufacturing Market Overview
10.4.2 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis
10.4.3 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.4.4 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.4.5 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Vaccine Contract Manufacturing Market
10.4.6.1.1 South Africa Vaccine Contract Manufacturing Market by Vaccine Type
10.4.6.1.2 South Africa Vaccine Contract Manufacturing Market by Workflow Type
10.4.6.1.3 South Africa Vaccine Contract Manufacturing Market by Application
10.4.6.2 Saudi Arabia Vaccine Contract Manufacturing Market
10.4.6.2.1 Saudi Arabia Vaccine Contract Manufacturing Market by Vaccine Type
10.4.6.2.2 Saudi Arabia Vaccine Contract Manufacturing Market by Workflow Type
10.4.6.2.3 Saudi Arabia Vaccine Contract Manufacturing Market by Application
10.4.6.3 U.A.E Vaccine Contract Manufacturing Market
10.4.6.3.1 U.A.E Vaccine Contract Manufacturing Market by Vaccine Type
10.4.6.3.2 U.A.E Vaccine Contract Manufacturing Market by Workflow Type
10.4.6.3.3 U.A.E Vaccine Contract Manufacturing Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Vaccine Contract Manufacturing Market Overview
10.5.2 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis
10.5.3 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.5.4 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.5.5 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.5.6 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Vaccine Contract Manufacturing Market
10.5.6.1.1 Brazil Vaccine Contract Manufacturing Market by Vaccine Type
10.5.6.1.2 Brazil Vaccine Contract Manufacturing Market by Workflow Type
10.5.6.1.3 Brazil Vaccine Contract Manufacturing Market by Application
10.5.6.2 Argentina Vaccine Contract Manufacturing Market
10.5.6.2.1 Argentina Vaccine Contract Manufacturing Market by Vaccine Type
10.5.6.2.2 Argentina Vaccine Contract Manufacturing Market by Workflow Type
10.5.6.2.3 Argentina Vaccine Contract Manufacturing Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VACCINE CONTRACT MANUFACTURING MARKET, KEY COMPANY PROFILES
12.1. LONZA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK KGAA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBVIE INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CYTOVANCE BIOLOGICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CATALENT, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. IDT BIOLOGIKA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ICON PLC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ALBANY MOLECULAR RESEARCH INC. (AMRI)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CHARLES RIVER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vaccine Contract Manufacturing Market - By Vaccine Type
1.3.2 Vaccine Contract Manufacturing Market - By Workflow Type
1.3.3 Vaccine Contract Manufacturing Market - By Application
1.3.4 Vaccine Contract Manufacturing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VACCINE CONTRACT MANUFACTURING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
5. VACCINE CONTRACT MANUFACTURING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VACCINE CONTRACT MANUFACTURING MARKET - GLOBAL MARKET ANALYSIS
6.1. VACCINE CONTRACT MANUFACTURING - GLOBAL MARKET OVERVIEW
6.2. VACCINE CONTRACT MANUFACTURING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VACCINE CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. INACTIVATED VACCINES
7.3.1. Overview
7.3.2. Inactivated Vaccines Market Forecast and Analysis
7.4. ATTENUATED VACCINES
7.4.1. Overview
7.4.2. Attenuated Vaccines Market Forecast and Analysis
7.5. SUBUNIT VACCINES
7.5.1. Overview
7.5.2. Subunit Vaccines Market Forecast and Analysis
7.6. TOXOID VACCINES
7.6.1. Overview
7.6.2. Toxoid Vaccines Market Forecast and Analysis
7.7. DNA VACCINES
7.7.1. Overview
7.7.2. DNA Vaccines Market Forecast and Analysis
8. VACCINE CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - WORKFLOW TYPE
8.1. OVERVIEW
8.2. WORKFLOW TYPE MARKET FORECASTS AND ANALYSIS
8.3. DOWNSTREAM
8.3.1. Overview
8.3.2. Downstream Market Forecast and Analysis
8.3.3. Fill & Finish Operations Market
8.3.3.1. Overview
8.3.3.2. Fill and Finish Operations Market Forecast and Analysis
8.3.4. Analytical & QC studies Market
8.3.4.1. Overview
8.3.4.2. Analytical and QC studies Market Forecast and Analysis
8.3.5. Packaging Market
8.3.5.1. Overview
8.3.5.2. Packaging Market Forecast and Analysis
8.4. UPSTREAM
8.4.1. Overview
8.4.2. Upstream Market Forecast and Analysis
8.4.3. Mammalian Expression Systems Market
8.4.3.1. Overview
8.4.3.2. Mammalian Expression Systems Market Forecast and Analysis
8.4.4. Bacterial Expression Systems Market
8.4.4.1. Overview
8.4.4.2. Bacterial Expression Systems Market Forecast and Analysis
8.4.5. Yeast Expression Systems Market
8.4.5.1. Overview
8.4.5.2. Yeast Expression Systems Market Forecast and Analysis
8.4.6. Baculovirus/Insect Expression Systems Market
8.4.6.1. Overview
8.4.6.2. Baculovirus/Insect Expression Systems Market Forecast and Analysis
8.4.7. Others Market
8.4.7.1. Overview
8.4.7.2. Others Market Forecast and Analysis
9. VACCINE CONTRACT MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HUMAN USE
9.3.1. Overview
9.3.2. Human Use Market Forecast and Analysis
9.4. VETERINARY
9.4.1. Overview
9.4.2. Veterinary Market Forecast and Analysis
10. VACCINE CONTRACT MANUFACTURING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Vaccine Contract Manufacturing Market Overview
10.1.2 North America Vaccine Contract Manufacturing Market Forecasts and Analysis
10.1.3 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.1.4 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.1.5 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.1.6 North America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Vaccine Contract Manufacturing Market
10.1.6.1.1 United States Vaccine Contract Manufacturing Market by Vaccine Type
10.1.6.1.2 United States Vaccine Contract Manufacturing Market by Workflow Type
10.1.6.1.3 United States Vaccine Contract Manufacturing Market by Application
10.1.6.2 Canada Vaccine Contract Manufacturing Market
10.1.6.2.1 Canada Vaccine Contract Manufacturing Market by Vaccine Type
10.1.6.2.2 Canada Vaccine Contract Manufacturing Market by Workflow Type
10.1.6.2.3 Canada Vaccine Contract Manufacturing Market by Application
10.1.6.3 Mexico Vaccine Contract Manufacturing Market
10.1.6.3.1 Mexico Vaccine Contract Manufacturing Market by Vaccine Type
10.1.6.3.2 Mexico Vaccine Contract Manufacturing Market by Workflow Type
10.1.6.3.3 Mexico Vaccine Contract Manufacturing Market by Application
10.2. EUROPE
10.2.1 Europe Vaccine Contract Manufacturing Market Overview
10.2.2 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis
10.2.3 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.2.4 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.2.5 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.2.6 Europe Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Vaccine Contract Manufacturing Market
10.2.6.1.1 Germany Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.1.2 Germany Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.1.3 Germany Vaccine Contract Manufacturing Market by Application
10.2.6.2 France Vaccine Contract Manufacturing Market
10.2.6.2.1 France Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.2.2 France Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.2.3 France Vaccine Contract Manufacturing Market by Application
10.2.6.3 Italy Vaccine Contract Manufacturing Market
10.2.6.3.1 Italy Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.3.2 Italy Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.3.3 Italy Vaccine Contract Manufacturing Market by Application
10.2.6.4 Spain Vaccine Contract Manufacturing Market
10.2.6.4.1 Spain Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.4.2 Spain Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.4.3 Spain Vaccine Contract Manufacturing Market by Application
10.2.6.5 United Kingdom Vaccine Contract Manufacturing Market
10.2.6.5.1 United Kingdom Vaccine Contract Manufacturing Market by Vaccine Type
10.2.6.5.2 United Kingdom Vaccine Contract Manufacturing Market by Workflow Type
10.2.6.5.3 United Kingdom Vaccine Contract Manufacturing Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Vaccine Contract Manufacturing Market Overview
10.3.2 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis
10.3.3 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.3.4 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.3.5 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Vaccine Contract Manufacturing Market
10.3.6.1.1 Australia Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.1.2 Australia Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.1.3 Australia Vaccine Contract Manufacturing Market by Application
10.3.6.2 China Vaccine Contract Manufacturing Market
10.3.6.2.1 China Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.2.2 China Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.2.3 China Vaccine Contract Manufacturing Market by Application
10.3.6.3 India Vaccine Contract Manufacturing Market
10.3.6.3.1 India Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.3.2 India Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.3.3 India Vaccine Contract Manufacturing Market by Application
10.3.6.4 Japan Vaccine Contract Manufacturing Market
10.3.6.4.1 Japan Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.4.2 Japan Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.4.3 Japan Vaccine Contract Manufacturing Market by Application
10.3.6.5 South Korea Vaccine Contract Manufacturing Market
10.3.6.5.1 South Korea Vaccine Contract Manufacturing Market by Vaccine Type
10.3.6.5.2 South Korea Vaccine Contract Manufacturing Market by Workflow Type
10.3.6.5.3 South Korea Vaccine Contract Manufacturing Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Vaccine Contract Manufacturing Market Overview
10.4.2 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis
10.4.3 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.4.4 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.4.5 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Vaccine Contract Manufacturing Market
10.4.6.1.1 South Africa Vaccine Contract Manufacturing Market by Vaccine Type
10.4.6.1.2 South Africa Vaccine Contract Manufacturing Market by Workflow Type
10.4.6.1.3 South Africa Vaccine Contract Manufacturing Market by Application
10.4.6.2 Saudi Arabia Vaccine Contract Manufacturing Market
10.4.6.2.1 Saudi Arabia Vaccine Contract Manufacturing Market by Vaccine Type
10.4.6.2.2 Saudi Arabia Vaccine Contract Manufacturing Market by Workflow Type
10.4.6.2.3 Saudi Arabia Vaccine Contract Manufacturing Market by Application
10.4.6.3 U.A.E Vaccine Contract Manufacturing Market
10.4.6.3.1 U.A.E Vaccine Contract Manufacturing Market by Vaccine Type
10.4.6.3.2 U.A.E Vaccine Contract Manufacturing Market by Workflow Type
10.4.6.3.3 U.A.E Vaccine Contract Manufacturing Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Vaccine Contract Manufacturing Market Overview
10.5.2 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis
10.5.3 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Vaccine Type
10.5.4 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Workflow Type
10.5.5 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Application
10.5.6 South and Central America Vaccine Contract Manufacturing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Vaccine Contract Manufacturing Market
10.5.6.1.1 Brazil Vaccine Contract Manufacturing Market by Vaccine Type
10.5.6.1.2 Brazil Vaccine Contract Manufacturing Market by Workflow Type
10.5.6.1.3 Brazil Vaccine Contract Manufacturing Market by Application
10.5.6.2 Argentina Vaccine Contract Manufacturing Market
10.5.6.2.1 Argentina Vaccine Contract Manufacturing Market by Vaccine Type
10.5.6.2.2 Argentina Vaccine Contract Manufacturing Market by Workflow Type
10.5.6.2.3 Argentina Vaccine Contract Manufacturing Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VACCINE CONTRACT MANUFACTURING MARKET, KEY COMPANY PROFILES
12.1. LONZA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK KGAA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBVIE INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CYTOVANCE BIOLOGICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CATALENT, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. IDT BIOLOGIKA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ICON PLC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ALBANY MOLECULAR RESEARCH INC. (AMRI)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CHARLES RIVER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Lonza
2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
3. Merck KGaA
4. AbbVie Inc.
5. Cytovance Biologics
6. Catalent, Inc.
7. IDT Biologika
8. ICON plc.
9. Albany Molecular Research Inc. (AMRI)
10. Charles River
1. Lonza
2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
3. Merck KGaA
4. AbbVie Inc.
5. Cytovance Biologics
6. Catalent, Inc.
7. IDT Biologika
8. ICON plc.
9. Albany Molecular Research Inc. (AMRI)
10. Charles River